171 related articles for article (PubMed ID: 34559047)
1. Monitoring the therapeutic efficacy of CA4P in the rabbit VX2 liver tumor using dynamic contrast-enhanced MRI.
Han T; Duan Q; Yang R; Wang Y; Yin H; Meng F; Liu Y; Qian T
Diagn Interv Radiol; 2021 Sep; 27(5):587-594. PubMed ID: 34559047
[TBL] [Abstract][Full Text] [Related]
2. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic efficiency of the perfusion-related parameters in assessing the vascular disrupting agent (CA4P) response in a rabbit VX2 liver tumor model.
Meng F; Zou B; Yang R; Duan Q; Qian T
Acta Radiol; 2022 Sep; 63(9):1147-1156. PubMed ID: 34279135
[TBL] [Abstract][Full Text] [Related]
4. Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model.
Moon J; Kim JH; Choi D; Yang J; Lee MW; Choi YL; Rhim H
J Appl Clin Med Phys; 2016 Sep; 17(5):418-427. PubMed ID: 27685133
[TBL] [Abstract][Full Text] [Related]
5. intravoxel incoherent motion diffusion-weighted MRI assessing the effect of the vascular disrupting agent CA4P on VX2 liver tumors in rabbits.
Yang R; Wang Y; Duan Q; Qian T
Curr Med Imaging; 2023 Mar; ():. PubMed ID: 36876841
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy.
Ren Z; Feng G; Li B; Zhang C; Du Y
Sci Rep; 2024 Feb; 14(1):4557. PubMed ID: 38402352
[TBL] [Abstract][Full Text] [Related]
7. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
Ahn SJ; An CS; Koom WS; Song HT; Suh JS
Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the scope of intramedullary invasion of malignant bone tumor by DCE-MRI quantitative parameters in animal study.
Zhang Y; Tan Y; Dong C; Gao S; Xu W; Chen H
J Bone Oncol; 2019 Dec; 19():100269. PubMed ID: 31799112
[TBL] [Abstract][Full Text] [Related]
9. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
10. Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.
Yi Z; Xie M; Shi G; Cheng Z; Zeng H; Jiang N; Wu Z
Eur Radiol; 2022 Mar; 32(3):1601-1610. PubMed ID: 34491383
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Arterial Embolization Combined with Anti-vascular Agent Combretastatin A4 Phosphate Inhibits Growth and Vascularization of Liver Tumor in an Animal Model.
Zhao H; Wu ZZ; Ren Q; Wu JJ; Wang Y; Feng JW; Rao M; Deng Q; Hu HY
Curr Med Sci; 2022 Dec; 42(6):1240-1247. PubMed ID: 36462132
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.
Yao WW; Zhang H; Ding B; Fu T; Jia H; Pang L; Song L; Xu W; Song Q; Chen K; Pan Z
Radiol Med; 2011 Apr; 116(3):366-74. PubMed ID: 21298356
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
14. The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats.
Liu Y; De Keyzer F; Wang Y; Wang F; Feng Y; Chen F; Yu J; Liu J; Song S; Swinnen J; Bormans G; Oyen R; Huang G; Ni Y
Int J Cancer; 2018 Oct; 143(7):1817-1828. PubMed ID: 29707770
[TBL] [Abstract][Full Text] [Related]
15. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
16. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging.
Galbraith SM; Maxwell RJ; Lodge MA; Tozer GM; Wilson J; Taylor NJ; Stirling JJ; Sena L; Padhani AR; Rustin GJ
J Clin Oncol; 2003 Aug; 21(15):2831-42. PubMed ID: 12807936
[TBL] [Abstract][Full Text] [Related]
17. Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.
Surov A; Kim JY; Aiello M; Huang W; Yankeelov TE; Wienke A; Pech M
In Vivo; 2022; 36(1):398-408. PubMed ID: 34972741
[TBL] [Abstract][Full Text] [Related]
18. Comparison of semi-quantitative and quantitative dynamic contrast-enhanced MRI evaluations of vertebral marrow perfusion in a rat osteoporosis model.
Zhu J; Xiong Z; Zhang J; Qiu Y; Hua T; Tang G
BMC Musculoskelet Disord; 2017 Nov; 18(1):446. PubMed ID: 29137612
[TBL] [Abstract][Full Text] [Related]
19. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers.
Liu YW; De Keyzer F; Feng YB; Chen F; Song SL; Swinnen J; Bormans G; Oyen R; Huang G; Ni YC
World J Gastroenterol; 2018 Jul; 24(25):2710-2721. PubMed ID: 29991876
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
